Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Imaging of Post-Operative Low Dose Versus Standard Dose Dexamethasone in Patients with Primary or Metastatic Brain Tumors: a Randomized, Double-blinded Feasibility Study.

NCT05139043 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT05139043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05139043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Imaging of Post-Operative Low Dose Versus Standard Dose Dexamethasone in Patients with Primary or Metastatic Brain Tumors: a Randomized, Double-blinded Feasibility Study.
Lead sponsor
City of Hope Medical Center
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 9, 2022
Completion date
September 3, 2025
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant brain neoplasm, metastatic malignant neoplasm in the brain, recurrent malignant brain neoplasm